A Phase IA, Open-Label, Multiple-Dose, Dose Escalation Study to Investigate the Safety and Pharmacokinetics of the BTK Inhibitor BGB-3111 in Subjects with Indolent B-Cell Lymphoid Malignancies

Project: Research

Project Details

StatusActive
Effective start/end date5/12/194/12/24

Keywords

  • clinical trial
  • phase 1 study
  • treatment efficacy
  • treatment safety
  • lymphoma